Opinion
3:20-cv-06719-WHO
09-08-2021
In re BioMarin Pharmaceutical Inc. Securities Litigation
COOLEY LLP JOHN C. DWYER (136533) (dwyerjc@cooley.com) JESSICA VALENZUELA SANTAMARIA (220934) (jvs@cooley.com) ALEX KASNER (310637) Attorneys for Defendants BioMarin Pharmaceutical Inc., Jean-Jacques Bienaimé, Brian R. Mueller, and Henry J. Fuchs COOLEY LLP Jessica Valenzuela Santamaria (220934) John C. Dwyer (136533) Alex Kasner (310637) Attorneys for Defendants BioMarin Pharmaceutical Inc., Jean-Jacques Bienaime, Brian R. Mueller, and Henry J. Fuchs BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP Katherine M. Sinderson Salvatore Graziano (admitted pro hac vice) (salvatore@blbglaw.com) Jeroen Van Kwawegan (admitted pro hac vice) (jeroen@blbglaw.com) Katherine M. Sinderson (admitted pro hac vice) (katiem@blbglaw.com) Abe Alexander (admitted pro hac vice) (abe .alexander@blbglaw.com) Christopher R. Miles (admitted pro hac vice) (christopher.miles@blbglaw.com) Thomas Z. Serpber (pro hac vice motion pending) (thomas.sperber@blbglaw.com) Jonathan D. Uslaner (256898) (jonathanu@blbglaw.com) Lead Counsel for Lead Plaintiff and the Class
COOLEY LLP JOHN C. DWYER (136533) (dwyerjc@cooley.com) JESSICA VALENZUELA SANTAMARIA (220934) (jvs@cooley.com) ALEX KASNER (310637) Attorneys for Defendants BioMarin Pharmaceutical Inc., Jean-Jacques Bienaimé, Brian R. Mueller, and Henry J. Fuchs
COOLEY LLP Jessica Valenzuela Santamaria (220934) John C. Dwyer (136533) Alex Kasner (310637) Attorneys for Defendants BioMarin Pharmaceutical Inc., Jean-Jacques Bienaime, Brian R. Mueller, and Henry J. Fuchs
BERNSTEIN LITOWITZ BERGER & GROSSMANN LLP Katherine M. Sinderson
Salvatore Graziano (admitted pro hac vice) (salvatore@blbglaw.com)
Jeroen Van Kwawegan (admitted pro hac vice) (jeroen@blbglaw.com)
Katherine M. Sinderson (admitted pro hac vice) (katiem@blbglaw.com)
Abe Alexander (admitted pro hac vice) (abe .alexander@blbglaw.com)
Christopher R. Miles (admitted pro hac vice) (christopher.miles@blbglaw.com)
Thomas Z. Serpber (pro hac vice motion pending) (thomas.sperber@blbglaw.com)
Jonathan D. Uslaner (256898) (jonathanu@blbglaw.com)
Lead Counsel for Lead Plaintiff and the Class
WILLIAM H. ORRICK, UNITED STATES DISTRICT JUDGE
STIPULATION AND [PROPOSED[ ORDER TO RESCHEDULE MOTION TO DISMISS HEARING
Lead Plaintiff Arbejdsmarkedets Tillægspension (“ATP” or “Lead Plaintiff”) and Defendants BioMarin Pharmaceutical Inc., Jean-Jacques Bienaimé, Brian R. Mueller, and Henry J. Fuchs (“Defendants”) (collectively with ATP, the “Parties”) stipulate and agree as follows:
WHEREAS, on December 22, 2020, the Court issued an order appointing ATP Lead Plaintiff in the above-referenced action pursuant to the Private Securities Litigation Reform Act of 1995;
WHEREAS, on February 22, 2021, Lead Plaintiff filed an Amended Class Action Complaint;
WHEREAS, on April 22, 2021, Defendants filed a Motion to Dismiss Plaintiff's Amended Class Action Complaint and a Motion Hearing was set for September 8, 2021 at 2:00 p.m.;
WHEREAS, on June 22, 2021, Lead Plaintiff filed an Opposition to Defendants' Motion to Dismiss the Amended Class Action Complaint; Stipulation and [Proposed[ Order to Reschedule Motion to Dismiss
WHEREAS, on July 22, 2021, Defendants filed a Reply in Support of the Motion to Dismiss Plaintiff's Amended Class Action Complaint;
WHEREAS, on August 30, 2021, the Court entered a Clerk's Notice (“Order”) resetting the September 8, 2021 Motion Hearing to September 15, 2021 at 2:00 p.m.;
WHEREAS, counsel for Defendants have a professional conflict and will be unavailable for the rescheduled Motion Hearing;
WHEREAS, counsel for Defendants have another matter that is set for trial in the Northern District of California and will be unavailable for the duration of the trial;
WHEREAS, counsel for Defendants and for Lead Plaintiff have met and conferred and, at the request of counsel for Defendant and without objection from counsel for Lead Plaintiff, agreed to seek a continuance of the Motion Hearing from September 15, 2021 to November 17, 2021 at 2:00 p.m. or another date that is convenient for the Court.
NOW THEREFORE, the Parties, by and through their undersigned counsel, agree and stipulate to the following, subject to the Court's approval:
1. The Motion Hearing scheduled for September 15, 2021 at 2:00 p.m. shall be rescheduled to November 17, 2021 at 2:00 p.m.
IT IS SO STIPULATED.
ORDER
IT IS SO ORDERED.
ATTESTATION PURSUANT TO CIV. L.R. 5-1(I)(3)
Pursuant to Civil Local Rule 5-1(i)(3), I attest that concurrence in the filing of this document has been obtained from the other signatories.